First Aid, Chapter 4 Laboratory Tests, Immune complexes, Complement Flashcards

1
Q

What is the degree of complement activation by immunoglobulin in descending order?

A

IgM → IgG3 → IgG1 → IgG2.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How are immune complexes formed?

A

IgM or IgG antibodies specific for a soluble antigen bind to it, forming circulating immune complexes (ICs).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What happens if IgM or IgG binds to antigens on a normal host cell in a normal person?

A

If IgM or IgG binds to an antigen on a normal host cell, regulatory complement proteins, such as factor H and I, inactivate C3b to iC3b, thereby inhibiting IC formation. Thus, IC formation normally occurs only on foreign cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How are immune complexes eliminated?

A

C3b binds CR1 on RBCs, thus allowing transport of ICs to the liver and spleen, where they are eliminated by macrophages.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What equilibrium zone are large circulating immune complexes found at? Small immune complexes?

A
  • Large circulating ICs are formed at the zone of equivalence (Figure 4-24).
  • Small circulating ICs are formed at the zone of antigen or antibody excess. (see Figure 4-24).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which immunoglobulins can activate the classical complement pathway?

A

IgM and IgG (subclass IgG1, IgG2, and IgG3) can activate the classical complement pathway.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do immune complexes cause disease? How does measuring complement allow monitoring of disease burden in some diseases?

A

ICs that are not properly eliminated can cause inflammation, resulting in tissue injury. Excessive IC formation also results in complement consumption. Measuring, IC formation via complement consumption, allows for estimation of disease burden. Thus, C3 and C4 levels can be used to monitor disease activity (e.g., in SLE).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Where do circulating immune complexes deposit? What kind of inflammation does this cause and where?

A

Circulating ICs are deposited in vascular beds and complement, which leads to complement consumption and reduced levels of C3 and C4. This produces a neutrophilic inflammation, usually affecting small arteries, glomeruli, and synovial of joints, which results in clinical symptoms of vasculitis, nephritis, and arthritis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the antigen involved in SLE?

A

DNA, nucleoproteins, and others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is antigen involved in poststreptococcal glomerulonephritis?

A

Streptococcal cell wall antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the antigen involved in polyarteritis nodosa?

A

Hepatitis B virus surface antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the antigen involved in cryoglobinemia?

A

Hepatitis C virus or rheumatoid factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What pathway does immune complex formation lead to the activation of? What coats the immune complex, and what does this allow for?

A
  • IC formation leads to the activation of the classical complement pathway.
  • C1q, C4b, and C3b coat the IC, maintain its solubility, and act as ligands for receptors on WBCs and RBCs.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does conglutinin bind?

A

-Conglutinin: Binds iC3b, which can then be detected in an assay. Does not detect C3dg. iC3b is converted to C3dg within 1–8 hours of its generation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What receptors does the Raji cell have? What detects Raji cells? What causes false positive?

A

Raji cell: Burkitt’s cell line with receptors for C1q, C3b, C3bi, and C3d. ICs bind to Raji cells, which are detected by antihuman IgG (IgA or M). False positive with warm reactive antilymphocyte Abs (e.g., SLE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How does the C1q binding assay work? How do false positives occur?

A

C1q-binding assay: Radiolabeled C1q binds to circulating ICs and is then detected. False positives may occur with autoantibody to C1q, aggregated immunoglobulins, or heparin in test samples. C1q will also bind to polyanionic substances in serum, such as bacterial endotoxin or DNA, giving false positive results.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Type III hypersensitivity occurs with antigen or antibody excess?

A

Antigen excess results in the formation of small immune complexes that do not fix complement and are not cleared from circulation, leading to deposition in glomeruli, vessels, and joints.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are possible manifestations of complement deficiency?

A

Complement deficiency may manifest with increased susceptibility to infection, autoimmune or IC-mediated diseases, or with angioedema. The specific illness depends upon which complement component is involved.

19
Q

What does AH50 measure?

A

AH50: Measures lysis of unsensitized rabbit RBCs. Screens the alternative pathway.

20
Q

What does CH50 measure?

A

CH50: Assesses ability of serum to lyse sheep RBCs sensitized with rabbit IgM. Screens the classical pathway. Best single screen for complement abnormalities. Low CH50 implies that at least one of the components is missing or low.

21
Q

How is the function of MBL pathway measured?

A

Function of MBL pathway: Measured by an ELISA assay. Wells coated with mannan are incubated with patient’s serum-activation of MBL pathway, which results in production of C4b and C4d that are measured by using enzyme conjugated monoclonal antibodies.

22
Q

What is the most common cause of low complement level?

A

The most common cause of low complement level is a poorly handled specimen. Complement assays are very sensitive to breakdown at room temperature. Consequently, when abnormal results are obtained, the test should be repeated to confirm true low/absent complement.
Mnemonic

23
Q

What is the mnemonic for complement testing for AH50 and CH50?

A

rAbbit — AH50 — Alternative pathway Classic image to sleep → sheep jumping over Clouds — CH50 — Classical

24
Q

If CH50 is absent and AH50 is OK then what are the missing factors?

A

C1q, C1r, C1s, C2, or C4

25
Q

If CH50 is OK and AH50 is absent then what are the missing factors?

A

B or D (very rare), or Properdin

26
Q

If CH50 is absent and AH50 is absent then what are the missing factors?

A

C3, C5, C6, C7, C8, or C9

27
Q

If CH50 is absent and AH50 is absent and C3 is absent, the what are the missing factors?

A

Factor H or I

28
Q

How can you differentiate between a hereditary complement deficiency and an acquired one?

A

n an acquired complement deficiency, CH50 and/or AH50 will be low, as opposed to a hereditary defect, in which case CH50 and/or AH50 will be absent. Also, an acquired defect will manifest with multiple low complement components; whereas, a hereditary deficiency will manifest with only one component low or absent (Table 4-23).

29
Q

In HAE type 1, what are the levels of: C4, C1 inhibitor level, C1 inhibitor function, and C1q?

A

C4: low
C1 inhibitor level: low
C1 inhibitor function: low
C1q: normal

30
Q

In HAE type 2, what are the levels of: C4, C1 inhibitor level, C1 inhibitor function, and C1q?

A

C4: low
C1 inhibitor level: normal or elevated
C1 inhibitor function: low
C1q: normal

31
Q

In AAE, what are the levels of: C4, C1 inhibitor level, C1 inhibitor function, and C1q?

A

C4: low
C1 inhibitor level: low
C1 inhibitor function: low
C1q: low

32
Q

In HAE type 3, what are the levels of: C4, C1 inhibitor level, C1 inhibitor function, and C1q?

A

C4: normal
C1 inhibitor level: normal
C1 inhibitor function: normal
C1q: normal

33
Q

What disease is C1q autoantibody found in?

A

Found in patients with hypocomplementemic vasculitis

34
Q

What disease is C1 inhibitor autoantibody found in?

A

Found in some patients with acquired angioedema

35
Q

What disease is C3 nephritic factor found in?

A

Found in a few patients with SLE, associated with dense deposit disease (membranoproliferative glomerulonephritis type II) and partial lipodystrophy

36
Q

What complement defect would be expected in an individual with frequent Neisseria infections?

A

Terminal complement complex (C5, C6, C7, C8, C9).

37
Q

Various mutations in which gene have been associated with type III HAE?

A

Factor 12 mutation (Hageman Factor). The most common mutation involves a gain of function resulting in abnormal generation of bradykinin.

38
Q

Since complement is an acute phase reactant and decrease due to activation might be masked by increase in synthesis during an inflammatory epidose, how can complement be accurately measured?

A

The split products can be used to determine whether activation has occurred, because their increase occurs only when the complement enzymes are formed and active.

39
Q

How is complement measured?

A

Individual complement components are measured using immunoprecipitation assays, including nephelometry, RIA, RID, and ELISA techniques. The most definitive method for evaluating complement activation is quantitation of the fragments formed during the enzymatic cleavage steps.

40
Q

What are the complement split products measured as markers of classical pathway or lectin pathway activation?

A

C4a and C4d

41
Q

What are the complement split products measured as markers of the alternative pathway activation?

A

Bb

42
Q

What are the complement split products measured as markers of terminal pathway activation?

A

C3a, iC3b, C5a, and soluble C5b-9

43
Q

What is the significance of reduced C3 and C4 levels in SLE?

A

o Reduced levels in the setting of lupus nephritis is an important predictor of more severe disease and poor outcome.
o Total deficiency of C3 is associated with development of membranoproliferative glomerulonephritis.